Log in to save to my catalogue

In Silico and In Vitro Analysis of Sulforaphane Anti- Candida Activity

In Silico and In Vitro Analysis of Sulforaphane Anti- Candida Activity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_546b005b2b014bb4aed2ac7d00b75e90

In Silico and In Vitro Analysis of Sulforaphane Anti- Candida Activity

About this item

Full title

In Silico and In Vitro Analysis of Sulforaphane Anti- Candida Activity

Publisher

Switzerland: MDPI AG

Journal title

Antibiotics (Basel), 2022-12, Vol.11 (12), p.1842

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Oropharyngeal candidiasis/candidosis is a common and recurrent opportunistic fungal infection. Fluconazole (FLZ), one of the most used and effective antifungal agents, has been associated with a rise of resistant
species in immunocompromised patients undergoing prophylactic therapy. Sulforaphane (SFN), a compound from cruciferous vegetables, is...

Alternative Titles

Full title

In Silico and In Vitro Analysis of Sulforaphane Anti- Candida Activity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_546b005b2b014bb4aed2ac7d00b75e90

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_546b005b2b014bb4aed2ac7d00b75e90

Other Identifiers

ISSN

2079-6382

E-ISSN

2079-6382

DOI

10.3390/antibiotics11121842

How to access this item